Latest News from: Johns Hopkins Medicine

Filters close
Newswise: Media Advisory: Patients and Families Will Share Children’s Center Stories During Mix 106.5’s 34th Annual Radiothon
Released: 20-Feb-2023 9:00 AM EST
Media Advisory: Patients and Families Will Share Children’s Center Stories During Mix 106.5’s 34th Annual Radiothon
Johns Hopkins Medicine

What: Mix 106.5’s 34th Annual Radiothon benefiting Johns Hopkins Children’s Center kicks off this week on Thursday, Feb. 23, and runs through Friday, Feb. 24. It is the Children’s Center’s largest fundraising event of the year, and airs on the Baltimore radio station throughout the two days.

Newswise: Rapid Screening Test Predicts Effectiveness of Steroid Injections for Neck Pain
Released: 15-Feb-2023 9:00 AM EST
Rapid Screening Test Predicts Effectiveness of Steroid Injections for Neck Pain
Johns Hopkins Medicine

Researchers from Johns Hopkins Medicine and several other institutions say they have developed a quick clinical test that predicts which people with neck pain are more likely to benefit from epidural steroid injections, which deliver drugs directly around the spinal nerves to stop nerve inflammation and reduce pain.

Newswise: A Healthy Heart for Aidan
Released: 15-Feb-2023 8:00 AM EST
A Healthy Heart for Aidan
Johns Hopkins Medicine

If you look at Aidan Marcus, you would have no way of knowing everything he has gone through in his 17 months of life. His mom, Ambar, says, “He looks like a normal kid.” But when she was 22 weeks pregnant, she and her husband, Justin, who live in Silver Spring, Maryland, learned that their baby boy’s heart wasn’t developing properly. Aidan was diagnosed with hypoplastic left heart syndrome (HLHS), a congenital heart defect in which the left side of the heart is underdeveloped — a condition that affects about 1,000 newborns in the U.S. each year.

Newswise: CBD May Increase the Adverse Effects of THC in Edible Cannabis Products, Study Shows
Released: 13-Feb-2023 12:15 PM EST
CBD May Increase the Adverse Effects of THC in Edible Cannabis Products, Study Shows
Johns Hopkins Medicine

Contrary to some common claims, a study led by Johns Hopkins Medicine researchers found that relatively high doses of cannabidiol (CBD) may increase the adverse effects of delta-9-tetrahydrocannabinol (THC), the main active ingredient in cannabis that can cause a mood alteration or a “high” sensation. The findings show that in edible cannabis products, CBD inhibits the metabolism, or breakdown, of THC, which may result in stronger and longer drug effects.

Newswise: The Convergence of Epigenetics and Math to Predict and Intercept Cancer Cell Behavior
Released: 9-Feb-2023 3:45 PM EST
The Convergence of Epigenetics and Math to Predict and Intercept Cancer Cell Behavior
Johns Hopkins Medicine

It is now widely understood that cancer is a disease of acquired defects in genes and gene function. An article published Feb. 10 in Science, and authored by Andrew Feinberg, M.D., of the Johns Hopkins Kimmel Cancer Center and the Institute for Basic Biomedical Sciences (IBBS) and Andre Levchenko, Sc.D., M.S., of the Yale School of Engineering and Applied Science, addresses new quantitative approaches to better define and measure these defects in gene function, known as epigenetics, and their interplay with the genetic landscape of cancer.

Newswise: New Study Affirms Link Between Sickle Cell Disease and Risk of Increased Mortality in Pregnant People
Released: 2-Feb-2023 1:10 PM EST
New Study Affirms Link Between Sickle Cell Disease and Risk of Increased Mortality in Pregnant People
Johns Hopkins Medicine

Johns Hopkins Medicine researchers have further documented an association between a substantially higher risk of maternal morbidity and mortality among those with the inherited blood disorder sickle cell disease (SCD) compared to those without it. Their analysis, using a large national administrative database with records for pregnant people with SCD, found the maternal mortality rate was 26 times greater than the national average. This figure has not improved since the last time this population was assessed.

Newswise: Five Johns Hopkins Medicine Researchers Named Fellows of the American Association for the Advancement of Science
Released: 31-Jan-2023 10:05 AM EST
Five Johns Hopkins Medicine Researchers Named Fellows of the American Association for the Advancement of Science
Johns Hopkins Medicine

Five researchers from the Johns Hopkins University School of Medicine were elected as 2022 fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and a publisher of numerous journals, including Science.

Newswise: New Study Finds Depression, Poor Mental Health Linked to Higher Heart Disease Risks Among Young Adults
Released: 30-Jan-2023 10:00 AM EST
New Study Finds Depression, Poor Mental Health Linked to Higher Heart Disease Risks Among Young Adults
Johns Hopkins Medicine

Young adults who feel down or depressed are more likely to develop cardiovascular disease (CVD) and have poor heart health, according to a new study led by Johns Hopkins Medicine researchers who analyzed data from more than a half million people between the ages of 18 and 49. The findings add to a growing body of evidence connecting CVD with depression among young and middle-aged adults and suggest the relationship between the two could begin in early adulthood.

Newswise: Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains
Released: 27-Jan-2023 9:20 AM EST
Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains
Johns Hopkins Medicine

Johns Hopkins Medicine investigators say their research indicates a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant (MDR) strains

Newswise: Johns Hopkins Physicians and Engineers Develop Search for AI Program That Accurately Predicts Risk of 'ICU Delirium'
Released: 26-Jan-2023 11:00 AM EST
Johns Hopkins Physicians and Engineers Develop Search for AI Program That Accurately Predicts Risk of 'ICU Delirium'
Johns Hopkins Medicine

More than one-third of all people admitted to the hospital, and as many as 80% of all patients in an intensive care unit (ICU), develop delirium, a type of brain dysfunction marked by sudden bouts of confusion, inattention, paranoia, or even agitation and hallucinations. An intensivist at Johns Hopkins Medicine, in collaboration with Johns Hopkins University engineering students, report they have developed artificial intelligence (AI) algorithms that can detect the early warning signs of delirium and can predict — at any time during an ICU stay — a high risk of delirium for a significant number of patients.

Newswise: ‘Hard to Lose’ Mutations in Tumors May Predict Response to Immunotherapy
25-Jan-2023 9:15 AM EST
‘Hard to Lose’ Mutations in Tumors May Predict Response to Immunotherapy
Johns Hopkins Medicine

Investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have found that a subset of mutations within the overall TMB, termed “persistent mutations,” are less likely to be edited out as cancer evolves, rendering tumors continuously visible to the immune system and predisposing them to respond to immunotherapy.

Newswise: Keys to Making Immunotherapy Work Against Pancreatic Cancer Found in Tumor Microenvironment
Released: 26-Jan-2023 10:00 AM EST
Keys to Making Immunotherapy Work Against Pancreatic Cancer Found in Tumor Microenvironment
Johns Hopkins Medicine

A new study that analyzed the tumor microenvironment of pancreatic cancer revealed the cause of tumor cell resistance to immunotherapy and resulted in new treatment strategies.

Newswise: Researchers Unravel Why Episodes of Low Blood Sugar Worsen Eye Disease in People with Diabetes
Released: 26-Jan-2023 9:00 AM EST
Researchers Unravel Why Episodes of Low Blood Sugar Worsen Eye Disease in People with Diabetes
Johns Hopkins Medicine

People with diabetes who experience periods of low blood sugar — a common occurrence in those new to blood sugar management — are more likely to have worsening diabetic eye disease. Now, researchers at Johns Hopkins Medicine say they have linked such low blood sugar levels with a molecular pathway that is turned on in oxygen-starved cells in the eye.

Newswise: Nanofiber-Hydrogel Loaded with Stem Cells Shows Success Treating Severe Complication of Crohn’s Disease
Released: 25-Jan-2023 10:00 AM EST
Nanofiber-Hydrogel Loaded with Stem Cells Shows Success Treating Severe Complication of Crohn’s Disease
Johns Hopkins Medicine

In a new study using a rat model of Crohn’s disease, a biodegradable hydrogel composite loaded with stem cells, developed by Johns Hopkins Medicine researchers, in a collaborative effort with the Whiting School of Engineering, has shown significant success in treating perianal fistulas (PAF) — one of the many complications of Crohn’s disease.

Newswise: New Studies Suggest Social Isolation Is a Risk Factor for Dementia in Older Adults, Point to Ways to Reduce Risk
Released: 12-Jan-2023 10:00 AM EST
New Studies Suggest Social Isolation Is a Risk Factor for Dementia in Older Adults, Point to Ways to Reduce Risk
Johns Hopkins Medicine

In two studies using nationally representative data from the National Health and Aging Trends Study gathered on thousands of Americans, researchers from the Johns Hopkins University School of Medicine and Bloomberg School of Public Health have significantly added to evidence that social isolation is a substantial risk factor for dementia in community-dwelling (noninstitutionalized) older adults, and identified technology as an effective way to intervene.

Newswise: Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus’ Initial Mutation that Enabled Its Spread
Released: 12-Jan-2023 9:00 AM EST
Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus’ Initial Mutation that Enabled Its Spread
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.

Newswise: The Nose Knows: Study Suggests It May Be Wise to Screen for Smell Loss to Predict Frailty and Unhealthy Aging
Released: 10-Jan-2023 9:40 AM EST
The Nose Knows: Study Suggests It May Be Wise to Screen for Smell Loss to Predict Frailty and Unhealthy Aging
Johns Hopkins Medicine

In a study using data from nearly 1,200 older adults, Johns Hopkins Medicine researchers have added to a growing body of evidence that loss of the sense of smell is a predictive marker for an increased risk of frailty as people age.

Newswise: New Year, New Habits: Johns Hopkins Children’s Center Experts Weigh in on Tips to Kick-start Healthy Habits in 2023
Released: 9-Jan-2023 10:00 AM EST
New Year, New Habits: Johns Hopkins Children’s Center Experts Weigh in on Tips to Kick-start Healthy Habits in 2023
Johns Hopkins Medicine

The year 2023 is here. A new year symbolizes a fresh start and offers a renewed focus on health and well-being. Many people make resolutions regarding their health — and resolutions aren’t just for adults. They are for kids, too. Johns Hopkins Children’s Center experts are available to help parents kick-start healthy habits for their children and families in 2023.

Newswise: Taming Overactive mTOR in Renal Cell Cancer
Released: 3-Jan-2023 11:00 AM EST
Taming Overactive mTOR in Renal Cell Cancer
Johns Hopkins Medicine

In a new study from the Johns Hopkins Kimmel Cancer Center, researchers described a novel mechanism of tumor formation in kidney cancers.

Newswise: When Grandpa Can’t Hear Words at a Noisy Holiday Gathering, Too Many Brain Cells May Be Firing at Once, Say Researchers
Released: 22-Dec-2022 1:30 PM EST
When Grandpa Can’t Hear Words at a Noisy Holiday Gathering, Too Many Brain Cells May Be Firing at Once, Say Researchers
Johns Hopkins Medicine

Looking for answers about how the brain works amid age-related hearing loss, Johns Hopkins Medicine researchers say they found that old mice were less capable than young mice of “turning off” certain actively firing brain cells in the midst of ambient noise.

Newswise: Found! Lost Puzzle Piece Involved in Gene Regulation Revealed in Search That Began in Water-Loving, One-Celled Organism
Released: 22-Dec-2022 10:00 AM EST
Found! Lost Puzzle Piece Involved in Gene Regulation Revealed in Search That Began in Water-Loving, One-Celled Organism
Johns Hopkins Medicine

After an intrepid, decade-long search, Johns Hopkins Medicine scientists say they have found a new role for a pair of enzymes that regulate genome function and, when missing or mutated, are linked to diseases such as brain tumors, blood cancers and Kleefstra syndrome — a rare genetic, neurocognitive disorder.

Newswise: Program That Trains Community Health Workers to Deliver Hearing Care Shows Success Among Low-Income Older Adults
Released: 20-Dec-2022 11:20 AM EST
Program That Trains Community Health Workers to Deliver Hearing Care Shows Success Among Low-Income Older Adults
Johns Hopkins Medicine

A first-in-kind program that trains trusted older adult community health workers to fit and deliver low-cost hearing technology to peers with hearing loss significantly improved communication function among participants, according to the results of a randomized clinical trial led by Johns Hopkins Medicine researchers.

Newswise: New Computer Model Tracks Origin of Cell Changes That Drive Development
Released: 9-Dec-2022 5:05 PM EST
New Computer Model Tracks Origin of Cell Changes That Drive Development
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine say they have developed a computer model — dubbed quantitative fate mapping — that looks back in the developmental timeline to trace the origin of cells in a fully grown organism.

Newswise: Johns Hopkins Researchers Explore the Concept of Belief Changes Related to Psychedelic Experiences
Released: 9-Dec-2022 9:00 AM EST
Johns Hopkins Researchers Explore the Concept of Belief Changes Related to Psychedelic Experiences
Johns Hopkins Medicine

Johns Hopkins Medicine researchers continue their exploration into psychedelics and how these drugs may produce a wide range of profound changes in perception, cognition and mood.

Newswise: Clues Found Regarding Tumor Suppressor Gene’s Breast Cancer Activity
Released: 8-Dec-2022 10:00 AM EST
Clues Found Regarding Tumor Suppressor Gene’s Breast Cancer Activity
Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress formation of breast cancers.

Newswise:Video Embedded how-does-a-cell-move-pull-the-plug-on-the-electrical-charge-on-the-inner-side-of-its-membrane-say-scientists
VIDEO
Released: 8-Dec-2022 9:00 AM EST
How Does a Cell Move? ‘Pull the Plug’ on the Electrical Charge on the Inner Side of Its Membrane, Say Scientists
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine say that a key to cellular movement is to regulate the electrical charge on the interior side of the cell membrane, potentially paving the way for understanding cancer, immune cell and other types of cell motion. 

Newswise: Household Air Cleaners Improve Heart Health Among Individuals with COPD, Researchers Find
Released: 5-Dec-2022 10:00 AM EST
Household Air Cleaners Improve Heart Health Among Individuals with COPD, Researchers Find
Johns Hopkins Medicine

A six-month study led by Johns Hopkins Medicine researchers concludes that the use of portable home air purifiers can improve some markers of cardiovascular health in people with chronic obstructive pulmonary disease, or COPD

Newswise: 'Tis The Season to Focus on Your Mental Health
Released: 5-Dec-2022 9:00 AM EST
'Tis The Season to Focus on Your Mental Health
Johns Hopkins Medicine

Johns Hopkins Medicine experts can provide tips for managing your mental health amid the bustle of the holiday season.

Newswise: Johns Hopkins Researchers Generate Lab-Grown Human Tissue Model for Food Tube Cancer
Released: 1-Dec-2022 9:00 AM EST
Johns Hopkins Researchers Generate Lab-Grown Human Tissue Model for Food Tube Cancer
Johns Hopkins Medicine

Researchers discover that dual knockout of genes in organoids grown from human tissue generates a model of and potential therapeutic target for gastroesophageal junction cancer

Newswise: One of Two Widely Used Macular Degeneration Drugs Outperforming Other at Weaning Patients off Treatment at One Year, Preliminary Study Shows
Released: 30-Nov-2022 1:30 PM EST
One of Two Widely Used Macular Degeneration Drugs Outperforming Other at Weaning Patients off Treatment at One Year, Preliminary Study Shows
Johns Hopkins Medicine

A pilot, “look-back” study of information about 106 patients with “wet” age-related macular degeneration (AMD) treated at the Wilmer Eye Institute at Johns Hopkins Medicine has revealed that nearly half of patients treated with aflibercept could safely stop eye injection therapy after one year without further vision loss.

Newswise: Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Released: 29-Nov-2022 5:25 PM EST
Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Johns Hopkins Medicine

Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.

Newswise: ‘You can always make a change’: 15-Year-Old Johns Hopkins Patient with Type 2 Diabetes Thrives Almost 2 Years After Diagnosis
Released: 28-Nov-2022 3:05 PM EST
‘You can always make a change’: 15-Year-Old Johns Hopkins Patient with Type 2 Diabetes Thrives Almost 2 Years After Diagnosis
Johns Hopkins Medicine

November is National Diabetes Awareness Month. Youth onset type 2 diabetes is rising worldwide, and a recent study by researchers at Johns Hopkins Children’s Center, published in the Journal of Pediatrics, documented a steep rise in new diagnoses of type 2 diabetes among children during the early part of the COVID-19 pandemic

Newswise: Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial Infections
Released: 21-Nov-2022 10:00 AM EST
Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial Infections
Johns Hopkins Medicine

PCORI funding will support trial to see if early transition to oral antibiotic therapy from intravenous administration improves outcomes for patients with gram-negative bloodstream infections

Newswise: Novel AI Blood Test Detects Liver Cancer
17-Nov-2022 2:00 PM EST
Novel AI Blood Test Detects Liver Cancer
Johns Hopkins Medicine

A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.

Newswise: Wearable Activity Trackers Can Be Used to Determine Health Metrics That Could Support Clinical Care
Released: 17-Nov-2022 12:00 PM EST
Wearable Activity Trackers Can Be Used to Determine Health Metrics That Could Support Clinical Care
Johns Hopkins Medicine

A new Johns Hopkins study shows that data gathered from wearable activity trackers can be used to obtain several metrics associated with the user’s general physical health and cardiovascular health status.

Newswise: Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed
Released: 16-Nov-2022 4:30 PM EST
Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed
Johns Hopkins Medicine

Newly published study in mice show augmented drug eliminates cancer cells without causing toxicity.

Newswise: Machine Learning Can Help Predict Patient Response to Cancer Immunotherapy
Released: 16-Nov-2022 10:00 AM EST
Machine Learning Can Help Predict Patient Response to Cancer Immunotherapy
Johns Hopkins Medicine

In a small study, Johns Hopkins Kimmel Cancer Center researchers successfully trained a machine learning algorithm to predict, in hindsight, which patients with melanoma would respond to treatment and which would not respond.

   
Newswise: Perspective: Audio Phone Visits with Medical Providers Remain Crucial Links to Delivering Equitable Health Care, Say Johns Hopkins Medicine Experts
Released: 14-Nov-2022 9:00 AM EST
Perspective: Audio Phone Visits with Medical Providers Remain Crucial Links to Delivering Equitable Health Care, Say Johns Hopkins Medicine Experts
Johns Hopkins Medicine

Writing in the Nov. 17 issue of the New England Journal of Medicine, two telemedicine experts and a historian at Johns Hopkins Medicine say audio-only telephone visits are an essential link to health care providers for patients without access to video visit options.

Newswise: Johns Hopkins Presents Initial Design of Building Named in Honor of Henrietta Lacks to Baltimore’s Urban Design and Architecture Advisory Panel
Released: 10-Nov-2022 1:05 PM EST
Johns Hopkins Presents Initial Design of Building Named in Honor of Henrietta Lacks to Baltimore’s Urban Design and Architecture Advisory Panel
Johns Hopkins Medicine

Johns Hopkins University and Johns Hopkins Medicine today presented the initial design plans for the on-campus building project named in honor of Henrietta Lacks, the Baltimore County woman whose cells have advanced medicine around the world, during an Urban Design and Architecture Advisory Panel meeting for Baltimore City Planning.

   
Newswise: Extracellular Viscosity Linked to Cancer Spread
2-Nov-2022 9:00 AM EDT
Extracellular Viscosity Linked to Cancer Spread
Johns Hopkins Medicine

New research findings show how higher viscosity, or resistance to flow, of the extracellular fluid that surrounds cells enables cancer cells to migrate more rapidly from a primary tumor to other sites in the body.

Newswise: Study Identifies Potential New Treatment Target for Sleep Apnea
Released: 31-Oct-2022 10:00 AM EDT
Study Identifies Potential New Treatment Target for Sleep Apnea
Johns Hopkins Medicine

In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people.

Newswise: Proof-of-Concept Study Advances Potential New Way to Deliver Gene Therapy
Released: 27-Oct-2022 1:30 PM EDT
Proof-of-Concept Study Advances Potential New Way to Deliver Gene Therapy
Johns Hopkins Medicine

Johns Hopkins Medicine researchers say they have successfully used a cell’s natural process for making proteins to “slide” genetic instructions into a cell and produce critical proteins missing from those cells.

Newswise: Neuroimaging Study Reveals Functional and Structural Brain Abnormalities in People with Post-Treatment Lyme Disease
Released: 26-Oct-2022 2:40 PM EDT
Neuroimaging Study Reveals Functional and Structural Brain Abnormalities in People with Post-Treatment Lyme Disease
Johns Hopkins Medicine

In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the “white matter” and other brain tissue physiology of those with post-treatment Lyme disease, a condition affecting 10% to 20% of the nearly half a million Americans who contract Lyme disease annually.

Newswise: Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine
Released: 19-Oct-2022 12:05 PM EDT
Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine
Johns Hopkins Medicine

The annual influenza (flu) season — which typically lasts from October to April in the United States — is upon us. Johns Hopkins Medicine experts will be available throughout the 2022–23 season for interviews about this year’s flu virus and flu vaccine, as well as other respiratory illnesses, such as COVID-19 and monkeypox.

Newswise: Can Obesity and Stress Influence Appetite? New Johns Hopkins Study Shows It’s All In Your Head
Released: 19-Oct-2022 9:00 AM EDT
Can Obesity and Stress Influence Appetite? New Johns Hopkins Study Shows It’s All In Your Head
Johns Hopkins Medicine

In a series of experiments using functional magnetic resonance imaging (fMRI) to measure brain activity across networks in the brain, Johns Hopkins Medicine researchers looked at how stress might increase appetite in obese and lean adults.

Newswise: Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Released: 13-Oct-2022 8:00 AM EDT
Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Johns Hopkins Medicine

It’s that time of year: costumes, candy and trick-or-treating. As families celebrate this season, Johns Hopkins Children’s Center experts are available for interviews on a variety of tips to help ensure a safe and fun Halloween.

Newswise: Blood Levels of ‘Free Range’ DNA May Signal Early Detection of Dementia and Frailty
Released: 11-Oct-2022 10:00 AM EDT
Blood Levels of ‘Free Range’ DNA May Signal Early Detection of Dementia and Frailty
Johns Hopkins Medicine

In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.

Newswise: Tip Sheet: Johns Hopkins Experts Present on Immigrant Mental Health, Reproductive Health Care and More at National Pediatrics Meeting
Released: 8-Oct-2022 8:00 AM EDT
Tip Sheet: Johns Hopkins Experts Present on Immigrant Mental Health, Reproductive Health Care and More at National Pediatrics Meeting
Johns Hopkins Medicine

Johns Hopkins Children’s Center researchers will present on several different topics at the AAP Experience National Conference & Exhibition.

Newswise: Researchers Find Link Between Immune Cells’ Closest Neighbors and Survival Time in Patients with Pancreatic Cancer
Released: 6-Oct-2022 1:00 PM EDT
Researchers Find Link Between Immune Cells’ Closest Neighbors and Survival Time in Patients with Pancreatic Cancer
Johns Hopkins Medicine

Researchers from Johns Hopkins Medicine have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and how long they survive.



close
0.26703